【ChiCTR2500108220】Efficacy of a mindfulness-based intervention with and without virtual reality support to promote mental health through self-compassion and mind wandering among university students: A randomised controlled trial
ChiCTR2500108220
尚未开始
/
/
/
2025-08-26
/
/
N/A
Efficacy of a mindfulness-based intervention with and without virtual reality support to promote mental health through self-compassion and mind wandering among university students: A randomised controlled trial
Efficacy of a mindfulness-based intervention with and without virtual reality support to promote mental health through self-compassion and mind wandering among university students: A randomised controlled trial
The aims of the current study are to explore the effectiveness of combining mindfulness practices with VR technology in improving neuropsychological and mental health outcomes, as well as to gain better understanding of how mindfulness impact on mental wellbeing through self-compassion and mind wandering. Utilizing a two-arm RCT design, the objectives of the present study are: (1) To assess the effectiveness of mindfulness-based intervention (MBI) with VR component on neuropsychological and mental health outcomes among university students, and (2) To investigate the relationship among mindfulness, self-compassion, mind wandering, and mental health outcomes.
随机平行对照
其它
Predetermined block randomisation list generated by computer
None
/
/
35
/
2025-08-25
2026-06-30
/
(1) Aged 18 or above, (2) Chinese with the ability to speak Cantonese or English, (3) able to provide written informed consent.；
请登录查看(1) with epilepsy or mental disorder diagnosis and currently on active medical or psychological treatment, and (2) likely to engage in immediate risk behaviour, such as suicide and/or violence.；
请登录查看Hong Kong Shue Yan University
/
Hong Kong Shue Yan University的其他临床试验
Department of Counselling & Psychology, Hong Kong Shue Yan University的其他临床试验
最新临床资讯
-
Nature子刊| 恒瑞HER2 ADC：81.5%患者肿瘤缓解，为何病理“清零”仅3.1%？
医药速览2026-08-31
-
首个！安进降脂药临床III期结果积极
医药速览2026-08-31
-
欧康维视2026-08-31
-
摩熵医药2026-08-31
-
摩熵医药2026-08-31
-
氨基观察2026-08-31
-
瞭望财经2026-08-31
-
药时代2026-08-31
-
Cytiva学堂2026-08-31
-
癌度2026-08-31
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-31
-
2026-08-31
-
2026-08-31
-
摩熵咨询 20 8
-
摩熵咨询 34 38
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
同适应症药物临床试验
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-31
-
2026-08-31
-
2026-08-31
-
摩熵咨询 35 47
-
摩熵咨询 28 48
-
摩熵咨询 34 28
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29